Trials / Completed
CompletedNCT02468089
To Compare the Efficacy of Carbepenem Versus Carbepenem Plus GM-CSF in Difficult To Treat Spontaneous Bacterial Peritonitis
A Randomized Study to Compare the Efficacy of Carbepenem Versus Carbepenem Plus GM-CSF in Difficult To Treat Spontaneous Bacterial Peritonitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 146 (actual)
- Sponsor
- Institute of Liver and Biliary Sciences, India · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A Minimum of 150 consecutive patients of decompensated cirrhosis of any etiology, presenting to the Institute of Liver and Biliary Sciences hospital with a diagnosis of difficult to treat SBP will be included and randomized into two treatment groups. Group A - Carbepenem+albumin Group B - Carbepenem+albumin+GMCSF.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Carbepenem | |
| DRUG | Albumin | |
| DRUG | GMCSF (of Granulocyte-Monocyte Colony-Stimulating Factor) . |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2017-08-31
- Completion
- 2017-08-31
- First posted
- 2015-06-10
- Last updated
- 2017-11-06
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT02468089. Inclusion in this directory is not an endorsement.